Promoting Endochondral Bone Repair Using Human Osteoarthritic Articular Chondrocytes

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Orthopedic Surgery

Background:

• Current bone defect treatments face challenges with graft integration and vascularization.
• Endochondral ossification offers an alternative for bone regeneration by stimulating angiogenesis and remodeling.
• Osteoarthritic (OA) articular chondrocytes, prone to hypertrophy, were investigated as a cell source for engineered cartilage grafts.

Purpose of the Study:

• To develop engineered endochondral cartilage grafts using human OA (hOA) chondrocytes.
• To evaluate the in vivo capacity of these grafts to undergo endochondral ossification and repair critical-size bone defects.

Main Methods:

• Scaffold-free cartilage grafts were engineered from passaged hOA chondrocytes using TGF-β1 and BMP4.
• Grafts were implanted subcutaneously or into critical-size mouse tibial defects.
• Bone formation and integration were assessed via histology and histomorphometry.

Main Results:

• Engineered grafts from passaged hOA chondrocytes successfully underwent endochondral ossification in vivo.
• Grafts integrated with host bone (15/16 junctions) and remodeled into woven bone, with 22-85% bony repair in defects.
• Half of the defects were bridged by new bone; unmodified OA cartilage and primary chondrocyte grafts failed to ossify.

Conclusions:

• Passaged hOA chondrocytes can be induced to an endochondral phenotype for cartilage graft engineering.
• Engineered endochondral cartilage grafts demonstrate potential for healing critical-size bone defects in a mouse model.
• Further optimization is necessary to enhance ossification and facilitate clinical translation.